Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Mar 14;8(1):164-8.
doi: 10.1159/000381014. eCollection 2015 Jan-Apr.

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report

Eric Dansin  1 , Aurélien Carnot  1 , Véronique Servent  2 , Dorothée Daussay  3 , Yves-Marie Robin  3 , Ecaterina Surmei-Pintilie  4 , Géraldine Lauridant  5 , Clothilde Descarpentries  6 , Françoise Révillion  7 , Claire Delattre  8
Affiliations
Case Reports

EGFR-Mutated Breast Metastasis of Lung Adenocarcinoma: A Case Report

Eric Dansin et al. Case Rep Oncol. .

Abstract

Breast metastasis from other primary carcinoma is very rare and could be difficult to identify despite immunohistochemistry analysis. Breast metastasis from lung adenocarcinoma can mimic triple-negative breast cancer. Given the prognosis and therapeutic challenges, a correct diagnosis appears essential, and molecular biomarkers could be useful. We report the case of a 52-year-old woman with a breast mass initially diagnosed as primary breast cancer and secondarily attached to breast metastasis from an EGFR-mutated lung adenocarcinoma. The same activating EGFR mutations were identified in both the primary lung carcinoma and the breast metastasis.

Keywords: Breast metastasis; EGFR mutation; EGFR tyrosine kinase inhibitors; Lung adenocarcinoma; Triple-negative breast cancer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Chest CT scan. Massive pleural effusion and left breast mass (arrow).
Fig. 2
Fig. 2
Chest CT scan. Primary lung cancer in the left upper lobe (arrow).
Fig. 3
Fig. 3
Breast biopsy. Histology features (a) and TTF1-positive immunostaining profile (b) for breast metastasis of the lung adenocarcinoma.
Fig. 4
Fig. 4
Chest CT scan. Objective response after 2 months of afatinib (arrow; see fig. 2 for baseline).
See this image and copyright information in PMC

References

    1. Lee AH. The histological diagnosis of metastases to the breast from extramammary malignancies. J Clin Pathol. 2007;60:1333–1341. - PMC - PubMed
    1. Hsu W, Sheen-Chen SM, Wang JL, Huang CC, Ko SF. Squamous cell lung carcinoma metastatic to the breast. Anticancer Res. 2008;28:1299–1301. - PubMed
    1. Masmoudi A, Mathieu MC, Soria JC. Breast metastasis from lung adenocarcinoma: a case report. Anticancer Res. 2003;23:1825–1826. - PubMed
    1. Liu W, Palma-Diaz F, Alasio TM. Primary small cell carcinoma of the lung initially presenting as a breast mass: a fine-needle aspiration diagnosis. Diagn Cytopathol. 2009;37:208–212. - PubMed
    1. Sousaris N, Mendelsohn G, Barr RG. Lung cancer metastatic to breast: case report and review of the literature. Ultrasound Q. 2013;29:205–209. - PubMed

Publication types